Find Experts

Experts in Haematology
Julio A Aguirre-Ghiso Alberto Toso Yan Xiaojing William G. Finn Afua Mensah Scott A. Armstrong Richard Oscar Francis Jose Javier Bravo Cordero Steven J Burakoff Arek Z. Dudek Balkrishna Jahagirdar Dan J. Schneider Dr. David Saunders Bamlaku Enawgaw Dylan Zylla Muhammad Yasin Tipu Mr. Máté SZILASSY Mr. Roberto MARCOS Mr. Brian CONIBERE Mr. Julio FREYRE View More
Johnnie Jose Orozco

Assistant Professor
Hematology
Fred Hutchinson Cancer Rearch Center
United States of America

Professor Haematology
Biography

Dr. Orozco is a hematology oncologist who specializes in treating patients with leukemia and lymphoma. Dr. Orzoco is actively involved in translational bench research, investigating novel therapeutic approaches for hematologic malignancies that are less toxic by improved targeting of therapy to the malignancy, and improving therapeutic options for patients. Education B.S., Chemical Engineering, University of California, Los Angeles, CA; 1995 Ph.D., Bioengineering, UW, Seattle, WA; 2004    M.D., Medical Scientist Training Program, UW School of Medicine; 2006 Internal Medicine Residency: University of California, San Francisco, CA; 2006-2009          Fellowship: UW, Hematology/Oncology Fellowship Program, Seattle, WA; 2009-2012      Research Associate, Clinical Research Division, FHCRC; 2013-2015 

Research Intrest

Hodgkin's lymphoma; anaplastic large-cell lymphoma; Burkitt’s lymphoma; chronic lymphocytic leukemia; diffuse large B-cell lymphoma; follicular lymphoma; low-grade lymphoma; mucosa-associated lymphoid tissue lymphoma; mantle cell lymphoma; marginal zone lymphoma; hairy cell leukemia.

List of Publications
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera. Miller BW, Frost SHL, Frayo SL, Kenoyer AL, Santos E, Jones JC, Green DJ, Hamlin DK, Wilbur DS, Fisher DR, Orozco JJ, Press OW, Pagel JM, Sandmaier BM; Med Phys. 2015-07-01.
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma. Graf, S. A.,Stevenson, P. A.,Holmberg, L. A.,Till, B. G.,Press, O. W.,Chauncey, T. R.,Smith, S. D.,Philip, M.,Orozco, J. J.,Shustov, A. R.,Green, D. J.,Libby, E. N.,Be...; Ann. Oncol.. 2015 Sep 09.
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma. Cassaday RD, Stevenson PA, Gooley TA, Chauncey TR, Pagel JM, Rajendran J, Till BG, Philip M, Orozco JJ, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Smith SD, Libb...; Br. J. Haematol.. 2015-12-01.
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission. Cowan, A. J.,Stevenson, P. A.,Cassaday, R. D.,Graf, S. A.,Fromm, J. R.,Wu, D.,Holmberg, L. A.,Till, B. G.,Chauncey, T. R.,Smith, S. D.,Philip, M.,Orozco, J. J.,Shustov...; Biol. Blood Marrow Transplant.. 2015 Sep 09.
Experts in United States of America
Jairaj K. Acharya John Belote Wayde Brown Aimée M. Dudley Jon P Mochel Rabaa M. Al-Rousan Chancellor, Renate Karen Lee Abt Lin Li Hui-Hsien Chou Hamed I. Aly Cory K. Adams Mark Ehrensberger Jose Buitrago Gerhard J. Barone Jacquelyne Adams Jon Calabria Shelley Cannady Susan B. Adams Stoica George Daniel E. Acuna Tal Amasay Jason R. Wiles Matthew H Andersen Brian Rothman View More